Whittemore Peterson Institute researcher makes major breakthrough
... in the immune response. Later in her career there, her work helped in the development of novel therapeutic agents for AIDS and AIDSassociated malignancies (Kaposi’s sarcoma). She agreed to work in Reno after attending a presentation by Dr. Daniel Peterson, medical director of the Whittemore Peterson ...
... in the immune response. Later in her career there, her work helped in the development of novel therapeutic agents for AIDS and AIDSassociated malignancies (Kaposi’s sarcoma). She agreed to work in Reno after attending a presentation by Dr. Daniel Peterson, medical director of the Whittemore Peterson ...
Full Text - Archives of Clinical Infectious Diseases
... Ranjbar and colleagues studied 102 admitted IDU patients in Hamadan during a 6-year period. They reported skin and soft tissue infection (%40.2), hepatitis and septicemia (%23.6) as the most common infections in this group of patients (7). Their findings are similar to ours; however, pulmonary infec ...
... Ranjbar and colleagues studied 102 admitted IDU patients in Hamadan during a 6-year period. They reported skin and soft tissue infection (%40.2), hepatitis and septicemia (%23.6) as the most common infections in this group of patients (7). Their findings are similar to ours; however, pulmonary infec ...
A case control study of environmental risk factors in
... autoimmune diseases among the family members of the MS patients as compared to controls. This is consistent with the presently held concepts of genetic risk and autoimmune pathogenesis of MS.31-32 The risk in siblings and fraternal twins of developing MS is about 2-5%, higher than in the normal popu ...
... autoimmune diseases among the family members of the MS patients as compared to controls. This is consistent with the presently held concepts of genetic risk and autoimmune pathogenesis of MS.31-32 The risk in siblings and fraternal twins of developing MS is about 2-5%, higher than in the normal popu ...
Practice Guideline: Epilepsy management in persons with mental
... history, a listing of other medical problems, hospitalizations, etc. Direct care staffs are responsible for recording recent events. If they are not using seizure tracking tools, providing and instructing them in their use will assist with your management. If seizures are reported, ask staff to prov ...
... history, a listing of other medical problems, hospitalizations, etc. Direct care staffs are responsible for recording recent events. If they are not using seizure tracking tools, providing and instructing them in their use will assist with your management. If seizures are reported, ask staff to prov ...
Management of Congestive Heart Disease
... In a study in 1984, it was found that serum levels of the neurotransmitter norepinephrine were elevated in direct correlation to the severity of heart failure. Originally betablocker was thought to be contraindicated in CHF as it should further weaken the heart. But in the end of the 20th century, i ...
... In a study in 1984, it was found that serum levels of the neurotransmitter norepinephrine were elevated in direct correlation to the severity of heart failure. Originally betablocker was thought to be contraindicated in CHF as it should further weaken the heart. But in the end of the 20th century, i ...
Use of Dental Appliances to Treat Sleep
... The initial diagnosis of SDB can only be made by a medical practitioner with training in sleep medicine, generally with the aid of a diagnostic sleep study. Oral appliances can be a first-line therapeutic option for people with snoring and mild to moderate forms of OSA. Oral appliances may also be i ...
... The initial diagnosis of SDB can only be made by a medical practitioner with training in sleep medicine, generally with the aid of a diagnostic sleep study. Oral appliances can be a first-line therapeutic option for people with snoring and mild to moderate forms of OSA. Oral appliances may also be i ...
Calcific Tendinitis - KentuckyOne Health
... results requiring their repair and extended rehabilitation. Are other treatments available for calcific tendinitis? Over the last decade, several reports have shown successful treatment of chronic calcific tendinitis with the use of shockwave therapy. Shockwave therapy is thought to work by inducing ...
... results requiring their repair and extended rehabilitation. Are other treatments available for calcific tendinitis? Over the last decade, several reports have shown successful treatment of chronic calcific tendinitis with the use of shockwave therapy. Shockwave therapy is thought to work by inducing ...
@ERSpublications Benzodiazepines, regardless of half-life, are associated with adverse respiratory outcomes...
... data reported annually to the World Health Organization. Out of 24 countries where ⩾75% of TB patients had a HIV test result and at least one HIV-positive MDR-TB case was reported, 11 showed a significant positive association between HIV and multidrug resistance among TB patients, mostly in countrie ...
... data reported annually to the World Health Organization. Out of 24 countries where ⩾75% of TB patients had a HIV test result and at least one HIV-positive MDR-TB case was reported, 11 showed a significant positive association between HIV and multidrug resistance among TB patients, mostly in countrie ...
NEW FINDINGS FROM OPHTHALMOLOGY, AJO, AND ARCHIVES
... ranibizumab for AMD. The authors found that a slight decline in visual acuity occurred over time and that different responder groups could be identified within the first two years of treatment. The study included 855 patients with AMD who were treated with ranibizumab during a four-year period. Of t ...
... ranibizumab for AMD. The authors found that a slight decline in visual acuity occurred over time and that different responder groups could be identified within the first two years of treatment. The study included 855 patients with AMD who were treated with ranibizumab during a four-year period. Of t ...
An International Phase 3 Multicenter
... – All patients are to receive open-label ECX (intravenous [IV] epirubicin 50 mg/m2 on day 1, IV cisplatin 60 mg/m2 on day 1, and oral capecitabine 625 mg/m2 twice daily on days 1−21) Q3W for a maximum of 10 cycles – Patients are randomized 1:1 to receive double-blind rilotumumab 15 mg/kg or placebo ...
... – All patients are to receive open-label ECX (intravenous [IV] epirubicin 50 mg/m2 on day 1, IV cisplatin 60 mg/m2 on day 1, and oral capecitabine 625 mg/m2 twice daily on days 1−21) Q3W for a maximum of 10 cycles – Patients are randomized 1:1 to receive double-blind rilotumumab 15 mg/kg or placebo ...
neurology - University of Mississippi Medical Center
... • Clinical—dissemination in time/space • Paraclinical—MRI brain/c-spine, LP, evoked potentials ...
... • Clinical—dissemination in time/space • Paraclinical—MRI brain/c-spine, LP, evoked potentials ...
Scott M. Macicek, Charles G. Macias, John L. Jefferies, Jeffrey... Price ; originally published online October 19, 2009;
... clinical characteristics, physician treatment patterns, and outcomes of patients who are hospitalized with acute HF syndromes (AHFS).3–5 Studies performed in the emergency setting have led to improved diagnostic accuracy and more effective management strategies for adult patients with AHFS.6–10 Such ...
... clinical characteristics, physician treatment patterns, and outcomes of patients who are hospitalized with acute HF syndromes (AHFS).3–5 Studies performed in the emergency setting have led to improved diagnostic accuracy and more effective management strategies for adult patients with AHFS.6–10 Such ...
HAART and Lipid Metabolism in a Resource Poor West African Setting
... the values observed are not as high as what is observed in the developed countries. It is important that physicians, nurses, AIDS service providers, and other health care professionals understand the potential liabilities and limitations of these drugs. Armed with these limitations, HIV caregivers w ...
... the values observed are not as high as what is observed in the developed countries. It is important that physicians, nurses, AIDS service providers, and other health care professionals understand the potential liabilities and limitations of these drugs. Armed with these limitations, HIV caregivers w ...
Clinical Slide Set. Multiple Sclerosis
... 1st-dose bradycardia often occurs; don’t use with β-blockers or if patient has known heart block Risk of retinal macular edema; eye exam required Varicella vaccination needed before treatment, if not immune ...
... 1st-dose bradycardia often occurs; don’t use with β-blockers or if patient has known heart block Risk of retinal macular edema; eye exam required Varicella vaccination needed before treatment, if not immune ...
PATHOGEN SAFETY DATA SHEET Streptococcus agalactiae
... Humans and Animals. Hand-to-mouth and aerosol transmission is common. 10-30% of women are positive in their genital tracts although the bacterium is normally a resident of the gastrointestinal tract. Shaking chills, chest pain, dyspnea, fever, productive cough, and sinusitis. Can cause middle ear in ...
... Humans and Animals. Hand-to-mouth and aerosol transmission is common. 10-30% of women are positive in their genital tracts although the bacterium is normally a resident of the gastrointestinal tract. Shaking chills, chest pain, dyspnea, fever, productive cough, and sinusitis. Can cause middle ear in ...
ROLUL RECUPERĂRII MEDICALE ÎN SINDROMUL
... pain, fatigue, functional impotence, cold intolerance, after a period of at least 15 years from acute polio virus infection, a period of neurological and functional stability, in the absence of other medical explanation [1]. The reported prevalence of PPS is between 15% and 80% of all patients with ...
... pain, fatigue, functional impotence, cold intolerance, after a period of at least 15 years from acute polio virus infection, a period of neurological and functional stability, in the absence of other medical explanation [1]. The reported prevalence of PPS is between 15% and 80% of all patients with ...
2014 Congestive Heart Failure
... The HF Treatment Algorithm from the American Heart Association and American College of Cardiology 2013 -HFrEF is Heart Failure Reduced Ejection Fraction which is less than or equal to 40% -HFpEF is Heart Failure with Preserved Ejection Fraction -GDMT is Goal Directed Medical Treatment -CHADS2 score: ...
... The HF Treatment Algorithm from the American Heart Association and American College of Cardiology 2013 -HFrEF is Heart Failure Reduced Ejection Fraction which is less than or equal to 40% -HFpEF is Heart Failure with Preserved Ejection Fraction -GDMT is Goal Directed Medical Treatment -CHADS2 score: ...
401-Chronic-Neuro2
... Describe the mechanism of action, side effects and nursing responsibilities with pharmacologic management of chronic neurological disorders. ...
... Describe the mechanism of action, side effects and nursing responsibilities with pharmacologic management of chronic neurological disorders. ...
RADIATION THERAPY ONCOLOGY GROUP
... internal iliac lymph nodes) will be treated to a target volume that would include pelvic nodes to the level of the L5-S1 interspace. The inferior margin will be at the bottom of the ischial tuberosity. In some patients ischial tuberosity may not be an appropriate landmark (patients with flat or elon ...
... internal iliac lymph nodes) will be treated to a target volume that would include pelvic nodes to the level of the L5-S1 interspace. The inferior margin will be at the bottom of the ischial tuberosity. In some patients ischial tuberosity may not be an appropriate landmark (patients with flat or elon ...
Functional β cells detected in long-standing T1DM
... seen to decrease gradually over the years. Of note, C-peptide was still detected in 10% of patients (n = 2) in the group with a 31–40 year disease duration. The researchers used an ultrasensitive C-peptide ELISA assay (Mercodia, Uppsala, Sweden) that detects levels of C-peptide >1.5 pmol/l, thus bei ...
... seen to decrease gradually over the years. Of note, C-peptide was still detected in 10% of patients (n = 2) in the group with a 31–40 year disease duration. The researchers used an ultrasensitive C-peptide ELISA assay (Mercodia, Uppsala, Sweden) that detects levels of C-peptide >1.5 pmol/l, thus bei ...
슬라이드 1
... Equal effectiveness Differences in adverse events LUTS secondary to BPH Very effective in relieving symptoms of BPH ...
... Equal effectiveness Differences in adverse events LUTS secondary to BPH Very effective in relieving symptoms of BPH ...
Peripheral(Neuropathy - Milwaukeefootspecialists.com
... Of course we always advocate that our diabetic patients stay on track with controlling their blood sugar. Keeping a well-‐regulated blood glucose will keep nerve damage from progressing further and makin ...
... Of course we always advocate that our diabetic patients stay on track with controlling their blood sugar. Keeping a well-‐regulated blood glucose will keep nerve damage from progressing further and makin ...
Bisphosphonates and osteonecrosis of the jaw
... necrotic bone in the maxilla or mandible that has persisted for more than eight weeks in patients taking or having taken a bisphosphonate and where there has been no history of radiation therapy to the jaw.’ Bisphosphonates, whether used for malignant conditions, osteoporosis or other conditions aff ...
... necrotic bone in the maxilla or mandible that has persisted for more than eight weeks in patients taking or having taken a bisphosphonate and where there has been no history of radiation therapy to the jaw.’ Bisphosphonates, whether used for malignant conditions, osteoporosis or other conditions aff ...
Complex Regional Pain Syndrome
... nerves and improve blood ow. Some individuals report temporary pain relief with this procedure, but there are limited data to support the long-term bene t of sympathetic nerve blocks. The use of surgical sympathectomy, which destroys some of the nerves, is controversial. Some experts think it is unn ...
... nerves and improve blood ow. Some individuals report temporary pain relief with this procedure, but there are limited data to support the long-term bene t of sympathetic nerve blocks. The use of surgical sympathectomy, which destroys some of the nerves, is controversial. Some experts think it is unn ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.